Y. Marcos et al., 2-LOCUS INVOLVEMENT IN THE ASSOCIATION OF HUMAN-LEUKOCYTE ANTIGEN WITH THE EXTRAHEPATIC MANIFESTATIONS OF AUTOIMMUNE CHRONIC ACTIVE HEPATITIS, Hepatology, 19(6), 1994, pp. 1371-1374
We investigated the association of human leukocyte antigen antigens an
d type I chronic active ''autoimmune'' hepatitis in a population of 65
white Argentinian patients, taking into account the different manifes
tations of the disease. Standard microlymphocytotoxicity was used for
human leukocyte antigen A, B, C, DR and DQ typing. Human leukocyte ant
igen class 2 alleles were also typed on genomic DNA by means of polyme
rase chain reaction amplification and hybridization to sequence specif
ic oligonucleotides. A primary association with human leukocyte antige
n DR4 was present (human leukocyte antigen DR4: 44% in patients vs. 29
% in controls; chi(2), 5.6; p = 0.02, relative risk, 2.1). However, a
novel association was observed with human leukocyte antigen All (31% i
n patients vs. 6% in the controls; chi(2), 25.3; corrected p = 0.001;
relative risk, 6.8). Moreover, of the 20 human leukocyte antigen All p
atients, 18 had extrahepatic manifestations associated with autoimmune
chronic active hepatitis. This represented 60% of the patients bearin
g this form of the disease (n = 30), conferring a relative risk of 22.
2 (chi(2), 46.3; corrected p = 0.00008). In this group, human leukocyt
e antigen DR3 and DR4 had a weak association. When present together, h
uman leukocyte antigen DR4 and human leukocyte antigen All had a syner
gistic effect, yielding an odds ratio of 357. Statistical analysis and
family segregation studies suggest that the two loci products may rep
resent independent risk factors for this form of autoimmune chronic ac
tive hepatitis. This synergistic effect was not evident with All plus
DR3. In autoimmune chronic active hepatitis patients without extrahepa
tic manifestations, a weak association with human leukocyte antigen DR
6 was found. Interestingly, in autoimmune chronic active hepatitis of
childhood (in which extrahepatic manifestations are seldom observed) a
strong association with human leukocyte antigen DR6 was recently obse
rved in patients from the same ethnic group and geographic region. The
clinical and genetic heterogeneity observed in this study may explain
the weak human leukocyte antigen associations reported previously for
autoimmune chronic active hepatitis and suggest that the extrahepatic
forms in patients with autoimmune chronic active hepatitis represents
a separate clinical entity.